May 26-28, 2022: PD Neurotechnology® was present as an exhibitor and a bronze sponsor at the 4th Pan American Parkinson’s Disease and Movement Disorders Congress, held on May 26-28, in Miami Florida, a successful event with more than 400 registrants from 22 countries. The MDS PAS Congress 2022 was a unique opportunity for the company to introduce PDMonitor® to movement disorders specialists from the Americas and officially launch its commercialization pre-sales efforts in the region.
PD Neurotechnology® also organized its first US Medical Advisory Board meeting (MAB), which helped steer the company’s strategy in the US and lay the foundation for the next round of investigator driven clinical studies to prove PDMonitor®’s usefulness in daily practice.
Nikos Moschos, Founder and Business Director of PD Neurotechnology® commented: “It was a pleasure to welcome to our booth physicians and industry experts and to present them how PDMonitor® is driving a paradigm shift in Parkinson’s disease management. The US market presents a major opportunity and we can’t wait to make PDMonitor® available to the market for the benefit of Parkinson’s patients. In this effort, the support of our highly talented and visionary Medical Advisory Board will be insurmountable.”
Nikos Moschos, Founder & Business Director of PD Neurotechnology® & Ms. Kat Montalt at the booth
You can find the press release here